Literature DB >> 16104642

Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population.

A Johannessen1, E Omenaas, P Bakke, A Gulsvik.   

Abstract

SETTING: The incidence of chronic obstructive pulmonary disease (COPD) as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has not previously been examined.
OBJECTIVE: To estimate cumulative 9-year GOLD-defined COPD incidence in a general adult Norwegian population, to analyse sex, age, smoking habits and residential area as predictors, and to assess the level of underdiagnosis.
DESIGN: Based on a random stratified population sample examined in 1987-1988, 908 adults (71%) participated in a follow-up examination in 1996-1997. Associations between risk factors and COPD incidence were examined with logistic regression analyses.
RESULTS: The cumulative incidence of COPD among persons at risk in 1987-1988 was 6.1% (95% confidence interval [CI] 4.0-8.1). Adjusted odds ratios (OR) for current smokers and ex-smokers were 9.6 (95% CI 3.6-25.2) and 5.0 (95% CI 1.8-13.8), compared to never smokers. Risk for COPD incidence further increased with pack years. Subjects aged 45-74 had an OR of 9.8 (95% CI 4.3-22.5) relative to those aged 18-44. Sex and residential area were not significantly associated with COPD incidence. Only 43% of the incident cases had physician-diagnosed asthma, bronchitis, emphysema and/or COPD.
CONCLUSION: Approximately 6% developed COPD over 9 years. Smoking and aging were important incidence predictors. Our study suggests a substantial underdiagnosis of COPD among adults in this community.

Entities:  

Mesh:

Year:  2005        PMID: 16104642

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  22 in total

Review 1.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

2.  Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.

Authors:  Matthew R Gingo; M Patricia George; Cathy J Kessinger; Lorrie Lucht; Barbara Rissler; Renee Weinman; William A Slivka; Deborah K McMahon; Sally E Wenzel; Frank C Sciurba; Alison Morris
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

3.  Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients.

Authors:  Colin R Simpson; Julia Hippisley-Cox; Aziz Sheikh
Journal:  Br J Gen Pract       Date:  2010-07       Impact factor: 5.386

4.  Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.

Authors:  A Johannessen; E R Omenaas; P S Bakke; A Gulsvik
Journal:  Thorax       Date:  2005-08-05       Impact factor: 9.139

5.  Feasible and simple exclusion criteria for pulmonary reference populations.

Authors:  Ane Johannessen; Ernst R Omenaas; Geir Egil Eide; Per S Bakke; Amund Gulsvik
Journal:  Thorax       Date:  2007-03-27       Impact factor: 9.139

6.  Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD).

Authors:  Emily S Wan; Dawn L DeMeo; Craig P Hersh; Steven D Shapiro; Richard A Rosiello; Susan R Sama; Anne L Fuhlbrigge; Marilyn G Foreman; Edwin K Silverman
Journal:  Respir Med       Date:  2010-12-10       Impact factor: 3.415

7.  Risk factors for community-acquired pneumonia in German adults: the impact of children in the household.

Authors:  M Schnoor; T Klante; M Beckmann; B P Robra; T Welte; H Raspe; T Schäfer
Journal:  Epidemiol Infect       Date:  2007-02-12       Impact factor: 2.451

8.  Present and future costs of COPD in Iceland and Norway: results from the BOLD study.

Authors:  R Nielsen; A Johannessen; B Benediktsdottir; T Gislason; A S Buist; A Gulsvik; S D Sullivan; T A Lee
Journal:  Eur Respir J       Date:  2009-04-08       Impact factor: 16.671

9.  Consumption of cured meats and prospective risk of chronic obstructive pulmonary disease in women.

Authors:  Rui Jiang; Carlos A Camargo; Raphaelle Varraso; David C Paik; Walter C Willett; R Graham Barr
Journal:  Am J Clin Nutr       Date:  2008-04       Impact factor: 7.045

10.  [The prevalence of COPD in Austria--the expected change over the next decade].

Authors:  Natalie Firlei; Bernd Lamprecht; Lea Schirnhofer; Bernhard Kaiser; Michael Studnicka
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.